乳腺癌初始系统治疗期间的半衰减
1Department of Breast Surgery, Ibaraki Prefectural Central Hospital, Ibaraki Cancer Center, Kasama, Japan.
Case reports in oncology
|October 9, 2025
概括
一名为乳腺癌接受多塞塔塞尔 (DTX) 化疗的患者出现了模仿外围神经病变的症状. 然而,成像显示了椎脊髓瘤,强调了在DTX治疗期间差异诊断的重要性.
科学领域:
- 在瘤学瘤学.
- 神经学 神经学
- 化疗不良影响 化疗不良影响
背景情况:
- 多西 (DTX) 是乳腺癌的基石化疗.
- 周围神经病变是多塞塔克塞尔治疗的显著不良影响.
- 区分治疗诱导的神经病与其他神经疾病对于患者管理至关重要.
研究的目的:
- 报告一种罕见的宫脊髓瘤病例,该病例发生在乳腺癌的多塞塔克塞尔治疗期间.
- 为了强调诊断挑战在区分脊髓瘤从dcetaxel诱导的外围神经病变.
主要方法:
- 一名62岁的患有IIA期乳腺癌的女性患者接受了新辅助化疗,包括多塞.
- 临床表现逐渐麻木和半促使诊断工作.
- 磁共振成像 (MRI) 确定了椎脊髓损伤.
- 手术切除和病理检查证实了脑膜瘤.
主要成果:
- 患者在开始使用多塞塔塞尔后出现了与外围神经病变相一致的症状.
- 磁力共振扫描显示了椎脊髓瘤,与预期的神经病变不同.
- 脑膜瘤的手术切除导致了显著的神经恢复.
- 手术后,患者恢复了行走,残留的轻度麻木.
结论:
- 这一案例强调了需要考虑替代诊断的必要性,例如脊髓瘤,在接受多塞塔克塞尔治疗的患者中,这些患者有神经缺陷.
- 对脊髓瘤的及时诊断和手术干预可以带来有利的结果,即使是在化疗的背景下.
相关概念视频
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Peripheral Artery Disease V: Postoperative Nursing Management
376
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
376
Peripheral Artery Disease IV: Nursing Management
349
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
349


